Rua Life Sciences PLC
LSE:RUA

Watchlist Manager
Rua Life Sciences PLC Logo
Rua Life Sciences PLC
LSE:RUA
Watchlist
Price: 12.25 GBX Market Closed
Market Cap: 7.6m GBX

Profitability Summary

Rua Life Sciences PLC's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Rua Life Sciences PLC

Revenue
4.1m GBP
Cost of Revenue
-941k GBP
Gross Profit
3.2m GBP
Operating Expenses
-3.2m GBP
Operating Income
-20k GBP
Other Expenses
21k GBP
Net Income
1k GBP

Margins Comparison
Rua Life Sciences PLC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Rua Life Sciences PLC
LSE:RUA
7.6m GBP
77%
0%
0%
JP
Hoya Corp
TSE:7741
8.2T JPY
86%
30%
24%
CH
Alcon AG
SIX:ALC
31.4B CHF
54%
14%
10%
DK
Coloplast A/S
CSE:COLO B
123.5B DKK
68%
28%
13%
US
Align Technology Inc
NASDAQ:ALGN
11.4B USD
69%
16%
10%
UK
ConvaTec Group PLC
LSE:CTEC
5B GBP
56%
15%
9%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
46.4B CNY
68%
38%
36%
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
59%
2%
-6%
CH
Ypsomed Holding AG
SIX:YPSN
4.4B CHF
41%
28%
25%
JP
Asahi Intecc Co Ltd
TSE:7747
811.7B JPY
68%
25%
11%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.2B USD
48%
11%
8%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Rua Life Sciences PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Rua Life Sciences PLC
LSE:RUA
7.6m GBP
0%
0%
0%
0%
JP
Hoya Corp
TSE:7741
8.2T JPY
21%
17%
24%
32%
CH
Alcon AG
SIX:ALC
31.4B CHF
5%
3%
5%
4%
DK
Coloplast A/S
CSE:COLO B
123.5B DKK
21%
8%
19%
10%
US
Align Technology Inc
NASDAQ:ALGN
11.4B USD
10%
6%
15%
8%
UK
ConvaTec Group PLC
LSE:CTEC
5B GBP
13%
6%
11%
8%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
46.4B CNY
20%
19%
21%
23%
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
-5%
-2%
1%
1%
CH
Ypsomed Holding AG
SIX:YPSN
4.4B CHF
27%
16%
28%
18%
JP
Asahi Intecc Co Ltd
TSE:7747
811.7B JPY
8%
7%
18%
14%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.2B USD
8%
5%
7%
7%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less